Download free PDF

Biorationals Market Size & Share 2026-2035

Report ID: GMI5657
   |
Published Date: November 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:

Biorationals Market Size

The biorationals market was valued at USD 6.5 billion in 2025 and is expected to reach USD 7.15 billion in 2026, advancing at a 10.00% CAGR (2026–2035) to USD 16.85 billion by 2035. The market covers pest, disease, nematode and weed control products whose active ingredient comes from a microorganism, plant extract, semiochemical or naturally occurring mineral or biochemical substance, including Bacillus thuringiensis, Trichoderma, Beauveria bassiana, neem, pyrethrin, pheromones, kaolin and sulphur. Biostimulants, biofertilizers, beneficial insects and conventional synthetic pesticides are outside the definition.

Biorationals Market Key Takeaways

2025 Market Size
$ 6.5 Billion
2026 Market Size
$ 7.15 Billion
2035 Forecast Market Size
$ 16.85 Billion
CAGR (2026–2035)
10%
Regional Dominance
Largest Market
Asia Pacific
Fastest Growing Region
Asia Pacific
Key Players
  • Market Leader: BASF SE led with over 6.92% market share in 2025.

  • Leading Players: Top 5 players in this market include BASF SE, Corteva Agriscience, Syngenta AG, Bayer AG, Sumitomo Chemical Co., Ltd., which collectively held a market share of 28.23% in 2025.

Growth reflects a change in how growers build spray programs more than a replacement of chemistry. Biorationals now fill resistance-management slots, short pre-harvest windows and residue-sensitive export programs, and large crop protection companies have moved from distribution agreements to owning fermentation capacity, strain libraries and registrations. That shift gives revenue durability, because a grower who has validated a biological in one season usually keeps it in the rotation, while launches remain paced by registration systems rather than by agronomic demand.

GMI Analyst View

Our discussions with industry experts indicate that the market moved 580 kilotons of product in 2025. That tonnage matters because biorationals are dosed at low rates per hectare and priced on activity rather than weight, so revenue growth depends as much on mix as on volume. The strongest value gains are likely to come from products where each unit carries more agronomic work than a bulk botanical or mineral input does.

Biorationals Market Trends, Growth Drivers & GMI Forecast Outlook

Regulatory reform and a widening approved-product list are pulling biorationals into mainstream crop programs, especially in Latin America and Europe, while slow registration reviews and field variability delay launches and keep adoption concentrated in high-value crops, which shapes both the timing and the mix of demand.

Key Drivers

DriverEvidence signalMarket-demand implicationGMI forecast condition
Brazil's registration surgeBrazil's agriculture ministry registered 162 bioinputs in 2025, a record, spanning biological, biochemical, plant-extract and semiochemical products [1].A faster flow of labels widens the biological menu for soybean, corn and sugarcane growers and gives distributors more products to sell into Brazil's large row-crop base.Supports Latin American demand through 2030; the effect strengthens if the federal bioinputs law's implementing rules keep a simplified route for products similar to ones already registered, and weakens if they add new data requirements.
Expanding approved list for microbials in the EUAn analysis of the EU Pesticides Database through 2025 shows 73 microorganisms currently approved as active substances [2].A deeper approved list gives European formulators more registered microbial products to sell into vines, fruit and vegetables, where chemical actives keep leaving the market.Supports European demand through 2030; the effect strengthens if the Commission's biocontrol fast-track proposal is adopted without dilution, and weakens if member states keep product authorizations slow.
Residue-driven buyer standards in export horticultureExport packers and retailers set residue limits that exclude many late-season synthetic sprays on fruit and vegetables.Growers of berries, grapes, tomatoes and leafy vegetables book biologicals into the last weeks before harvest, where a short pre-harvest interval decides the choice of product.Supports fruit and vegetable demand through 2035; stronger if importing markets tighten residue limits on synthetic actives, weaker if packers accept higher residue tolerances.

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Brazil's record year matters less for the count than for what it does to launch timing. A company that can list a Bacillus or Trichoderma product in a year rather than several is able to match launches to the soybean and sugarcane calendars, and it can register narrower, crop-specific labels instead of one broad claim. Distributors respond by stocking more biological lines next to chemical programs. Another route is on-farm production, which the federal bioinputs law exempts from registration when material is used by the producer itself, so commercial suppliers compete with growers' own biofactories on price. The forecast therefore leans on registered, quality-assured products winning share from home brewing.

In Europe the demand mechanism is substitution under pressure. Each non-renewed chemical fungicide or insecticide leaves a gap in a vine, orchard or vegetable program, and the growing list of approved microorganisms such as Bacillus subtilis, Bacillus amyloliquefaciens and Beauveria bassiana is the first place technical advisers look for a replacement. Product authorization still happens country by country, so a microbial active that is approved at EU level may reach French growers well before Greek ones. The forecast assumes steady, not abrupt, uptake: approved actives become products only as national dossiers clear, and the likeliest buyers are premium fruit, wine and protected-vegetable growers whose retailers already limit residues.

Residue standards act on behavior at the end of the growing cycle. A berry grower facing a retailer's residue ceiling cannot treat gray mold with a conventional fungicide in the final days before picking, but can apply a Bacillus- or Trichoderma-based product with no or a short harvest interval. The same logic applies to tomatoes under greenhouse programs and to export vegetables from Mexico, Kenya and Peru. This turns biorationals from an optional sustainability add-on into the compliance tool for the last spray, a more durable position because it is tied to a contract rather than a preference. If standards ease, volumes in this niche would soften quickly.

Key Restraints

RestraintEvidence signalMarket-demand implicationGMI forecast condition
Slow EU biocontrol assessmentsRapporteur Member States took an average of 3 years and 274 days to draft assessment reports for biocontrol active substances, according to Commission monitoring from May 2024 [3].New European microbial and semiochemical actives reach farmers years after development, which delays launches and holds back revenue from innovative products in the region.Holds back European launches through 2028; adoption of provisional authorizations and tacit mutual recognition would shorten the lag and lift the outlook, while unchanged timelines would lower it.
Late EPA biopesticide decisionsThe U.S. EPA completed 62% of its biopesticide registration decisions after the statutory deadline in fiscal 2025 [4].U.S. registrants plan launches around uncertain label dates, which slows new active ingredients and label expansions for specialty crops.Moderates North American growth through 2030; faster decisions on new actives and new uses would raise the U.S. outlook, and a larger backlog would lower it.
Field variability and handling limitsLiving products depend on temperature, humidity, storage and application timing, so performance differs more from field to field than for a synthetic standard.Growers of broad-acre cereals keep a chemical product as a fallback where margin per hectare is thin, which limits the share of acreage treated with biologicals.Caps adoption in cereals and grains for most of the forecast period; stable dry formulations and seed-applied products that cut handling risk would widen it before 2035.

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Europe's assessment time is the clearest example of regulation holding the market back. A biocontrol active submitted to a rapporteur member state waits years for the draft report before peer review and product authorizations can even begin, and the Commission's own staff paper attributes the delay to unclear categorization of plant extracts and microbial metabolites, a shortage of microbiologists and zonal procedures that miss their deadlines [3]. Small European baculovirus, pheromone and microbial developers carry that wait on their balance sheets, and larger companies steer launches toward Brazil and the United States first. The forecast assumes the Commission's proposals reduce but do not remove the lag before 2030.

The U.S. pattern is slower than the statute allows rather than slower than elsewhere. When most biopesticide decisions arrive late, a registrant cannot commit manufacturing capacity or sales training to a new strain with confidence, and small developers that rely on a single approval for their financing feel it most. The effect lands in specialty crops, where biopesticides are the main route to new uses, rather than in corn and soybean where large registrants can wait. Established products continue to expand label by label, so the restraint trims the pace of novelty more than it trims current sales, and it helps explain why North America trails the other regions on growth.

Field performance is the restraint that no regulation fixes. A Bacillus product sprayed in a hot afternoon or stored in a warehouse without temperature control can lose viable spores, and a grower who sees one weak result often reverts to the chemical standard for the next season. This weighs on cereals and grains, where each hectare earns little and a failed spray is costly. The answer inside the industry is formulation: dry granules, wettable powders, oil dispersions and seed coatings that protect the organism until it reaches the target. Suppliers that sell trial data and agronomic support alongside the product are likely to hold their position as the forecast moves from 2026 to 2035.

GMI Analyst View

The forecast rests on regulation and mix, forces that pull in the same direction in some markets and in opposite directions in others. Regulatory reform opens the door in Brazil and, eventually, in Europe, but dependence on slow authorization means the pace of launches will lag the pace of demand. Premium horticulture, vines and seed-applied products respond fastest, whereas broad-acre cereals follow only as formulation and price reduce performance risk. A reversal in any one of these conditions would shift the timing of growth more than its direction.

Biorationals Market Segment Analysis

By Type

Bioinsecticides

Biorationals Market Size By Type 2025 And 2035 Usd Billion
Biorationals Market Size By Type 2025 And 2035 Usd Billion

Bioinsecticides held a 42.00% share of 2025 revenue and are projected to reach USD 6.40 billion by 2035, which keeps them the largest type in the biorationals market even as faster-growing categories close the gap. Bacillus thuringiensis products, spinosyns and baculovirus formulations dominate, and they are bought for caterpillar and sap-feeder control in soybean, corn, cotton and vegetables where resistance has narrowed the choice of synthetic modes of action. Growers use them as a rotation partner rather than a replacement, which supports steady volume but limits how far the category can outgrow chemical insecticides.

Biofungicides

Biofungicides generated USD 1.95 billion in 2025 and are forecast to grow at 12.02% a year, the fastest rate among the named types. Bacillus subtilis and amyloliquefaciens, Trichoderma and Streptomyces products compete with copper, sulphur and conventional fungicide programs on grapes, berries, vegetables and soybean, where resistance management and residue limits shape the spray schedule. Their advantage over insecticides is a clear slot: they fit the early-season and pre-harvest windows that synthetic fungicides leave open, so adoption does not require growers to abandon a proven program.

Bionematicides

Bionematicides are expected to account for a 16.00% share of 2035 revenue and to grow at 10.71% a year, a pace slightly above the market average. Products built on Bacillus firmus, Purpureocillium lilacinum and related organisms serve fruit, vegetable, coffee and sugarcane growers in warm soils where nematode pressure is high and older fumigants and carbamate nematicides face restrictions. Because few synthetic replacements exist, biological nematicides often compete against nothing, and seed-applied formats are widening their reach into row crops.

Bioherbicides

Bioherbicides were worth USD 455 million in 2025 and are projected to reach USD 1.01 billion in 2035, making them the smallest named type. Weed control is the hardest task for a biological product, because plants do not respond to a living agent the way insects and fungi do, so commercial offerings rely largely on natural acids and plant-derived burndown chemistry in organic production and in non-crop areas near sensitive sites. Growth depends on new modes of action reaching registration rather than on conversion of conventional herbicide programs.

By Source

Microbial

Microbial products earned USD 3.25 billion in 2025 and are set to hold a 52.00% share in 2035, extending a lead built on Bacillus thuringiensis, Bacillus subtilis, Trichoderma and Beauveria bassiana. Live-organism products scale through fermentation capacity and strain libraries, which favors incumbents with plants and dossiers, and registration is organism by organism, so each new strain is a separate regulatory asset. The category covers all four product types, giving it the broadest exposure to growth in fungicides, nematicides and insecticides together.

Botanical

Botanicals held an 18.00% share of 2025 revenue and are projected to grow at 8.71% a year, slower than the market overall. Neem, pyrethrin and essential-oil products are sold mainly to organic growers and to protected vegetable and ornamental producers who value short re-entry and harvest intervals. Raw-material supply, batch-to-batch variability and short residual activity limit scale, so the category advances mostly through new extracts with a defined mode of action rather than through volume growth in the established plant oils.

Semiochemical

Semiochemicals were worth USD 780 million in 2025 and are projected to reach USD 2.36 billion by 2035. Pheromone mating-disruption dispensers for codling moth, grapevine moth and fruit borers are sold per hectare to orchard and vineyard growers as a season-long program, which gives suppliers repeat revenue. Synthetic pheromone manufacturing cost is the main lever: lower-cost production opens row crops and rice in Asia, where partnerships between large crop protection companies and pheromone specialists are directed.

Non-organic/Mineral

Mineral inputs are forecast at USD 2.19 billion in 2035 and are expected to grow at 8.44% a year. Kaolin clay, sulphur and copper compounds are inexpensive, widely accepted in organic standards and familiar to growers, so they anchor protected cropping and perennial crops. Their ceiling is regulatory: copper use limits in the European Union and residue concerns limit expansion, and competition from microbial fungicides is strongest where growers want a lower-load alternative to copper.

By Crop Type

Fruits & Vegetables

Biorationals Market Share By Crop Type 2025
Biorationals Market Share By Crop Type 2025

Fruits and vegetables accounted for USD 2.40 billion in 2025 and are projected to hold a 35.00% share in 2035. This is the most mature buyer group: growers of grapes, berries, tomatoes, apples and leafy vegetables sell into retail chains that set residue limits and publish approved-input lists, so biologicals sit inside written spray programs rather than being bought ad hoc. High crop value per hectare absorbs the higher cost of a biological, and short harvest intervals make these products the practical choice late in the season.

Cereals & Grains

Cereals and grains held 29.00% of 2025 revenue and are forecast to grow at 9.62% a year. Wheat, rice, corn and barley growers work with narrow margins per hectare, so biological use concentrates on seed treatments, soil-borne disease control and selected foliar programs rather than on whole-season replacement of chemistry. Rice in Asia and corn in the Americas are the main volume pools, and adoption depends on price parity and on products that tolerate the application equipment growers already own.

Oilseeds & Pulses

Oilseeds and pulses are projected to reach USD 4.38 billion in 2035, growing at 11.85% a year, the fastest rate among the named crop groups. Brazilian soybean drives the pattern: very large acreage, a heavy rotation of fungicides against rust and white mold, caterpillar pressure that favors baculovirus and Bacillus products, and seed-treatment channels controlled by the large suppliers. Soybean growers also have an unusually active biofactory culture, so commercial products compete with on-farm production.

By Mode of Application

Foliar Spray

Foliar spray delivered USD 3.25 billion in 2025 and is expected to hold a 46.00% share in 2035. It remains the default mode because growers already own sprayers and know the timing, and most biofungicides and bioinsecticides are formulated for leaf coverage. Its weakness is exposure: rain, sunlight and heat reduce survival of live organisms on the leaf, so suppliers compete on stickers, biofilm-forming strains and formulations that stay active after wash-off. Share erosion reflects seed and soil modes growing faster, not decline in foliar volume.

Soil Treatment

Soil treatment held a 25.00% share in 2025 and is projected to reach USD 4.21 billion by 2035. Drench, in-furrow granule and drip-irrigation applications deliver Trichoderma, Bacillus and nematode-active organisms to the root zone for vegetables, fruit trees, bananas and sugarcane. The method works where the pathogen lives in the soil and where irrigation systems allow repeated dosing, so adoption follows the spread of drip and fertigation infrastructure in Asia, Latin America and protected cultivation.

Seed Treatment

Seed treatment was worth USD 1.3 billion in 2025 and is forecast to grow at 12.48% a year, the fastest rate among the application modes. Treating seed at industrial plants puts a small, precise dose where the plant first meets soil pathogens, and it reaches growers through seed companies and distributors rather than through farm advisers. Seed-channel owners such as Syngenta, Bayer, Corteva and BASF are advantaged because they can bundle biologicals with chemical seed treatments, and shelf life on treated seed is the technical hurdle.

By Formulation

Liquid

Liquid formulations accounted for a 65.00% share of 2025 revenue and are projected to reach USD 10.45 billion by 2035. Suspension concentrates and oil dispersions are easy to mix and apply through existing equipment, which suits large growers and fits aerial and boom spraying. Cold storage, shelf life and settling during transport are the drawbacks, and these shape distribution in hot regions. The format keeps the lead because the biggest products, including Bacillus thuringiensis foliar sprays and microbial fungicides, were developed in liquid form.

Dry

Dry formulations were worth USD 2.27 billion in 2025 and are forecast to grow at 10.90% a year. Wettable powders, water-dispersible granules and spore-based powders last longer without refrigeration, travel better and suit warm-climate distribution in India, Southeast Asia, Africa and the Middle East. They also fit seed coatings and soil granules. The faster pace shows that logistics, not just efficacy, drives format choice, and that suppliers able to stabilize organisms in dry form can reach regions where cold chains are weak.

GMI Analyst View

Product, source and mode trends point the same way: the categories that gain are the ones that solve a specific timing or handling problem rather than those that offer a general natural alternative. Biofungicides, seed-applied products and dry formulations benefit because they fit existing practice and reduce performance risk, while bioherbicides and botanicals depend on new modes of action or supply improvements. Crop groups with high value per hectare, such as fruits and vegetables, will carry premium products, and oilseeds will carry volume. Suppliers with fermentation scale and channel control have the advantage.

Biorationals Market Regional Analysis

Biorationals Market Share By Region 2025 And 2035
Biorationals Market Share By Region 2025 And 2035

Asia Pacific Biorationals Market Analysis

Asia Pacific is projected to reach USD 6.09 billion in 2035 and to grow at 11.70% a year, the fastest rate among the regions of the biorationals market. The region combines very large numbers of smallholder rice, vegetable and tea growers with government programs to reduce chemical pesticide use in China, India, Japan and South Korea, so demand is shaped as much by registration capacity and distribution reach as by farm economics. Local manufacturers supply low-cost Bacillus, Trichoderma and neem products, while multinational suppliers focus on seed treatment and high-value horticulture.

China

China held a 28.00% share of Asia Pacific revenue in 2035 projections and was worth USD 564 million in 2025. Domestic producers of Bacillus thuringiensis, abamectin-derived products and Trichoderma dominate volumes, sold through a registration system run by the agriculture ministry's pesticide institute, while policy to cut chemical pesticide use in vegetables, tea and fruit supports demand. Foreign suppliers rely on joint ventures and local formulators, and price competition from domestic fermentation capacity keeps average selling prices low.

India

India accounted for a 20.00% share of Asia Pacific revenue in 2025 and is projected to reach USD 1.21 billion in 2035. Registration through the Central Insecticides Board and Registration Committee covers Trichoderma, Pseudomonas, Bacillus and neem-based products, and a large number of small and mid-size manufacturers sell through agro-dealers to cotton, vegetable, rice and pulse growers. State programs for natural and organic farming raise demand, and quality control of locally made microbial products is the main issue for larger suppliers entering the market.

Japan

Japan was worth USD 302 million in 2025 and is projected to reach USD 913 million in 2035. Aging farm labor and protected horticulture favor products that are easy to apply and have no re-entry delays, and the government's Strategy for Sustainable Food Systems sets a long-term direction toward lower chemical pesticide risk. Sumitomo Chemical's home market supports domestic suppliers of microbial and nature-derived products, and strict registration data requirements keep new entrants few.

South Korea

South Korea represented a 7.00% share of Asia Pacific revenue in 2025 and USD 426 million in 2035 projections. Greenhouse strawberries, melons, peppers and tomatoes are intensively managed and heavily sprayed, and organic-certified input lists support Bacillus, Trichoderma and plant-extract products. The country is small in cultivated area but dense in protected cropping, which supports premium, easy-to-apply products and favors import-friendly suppliers that can meet local registration rules.

North America Biorationals Market Analysis

North America was worth USD 1.49 billion in 2025 and is projected to reach USD 3 billion in 2035. Demand centers on specialty crops, such as fruit, nuts, vegetables and greenhouse production, together with organic acreage that requires approved inputs. Growers there use biologicals chiefly for resistance management and residue limits, while row-crop use is smaller and depends on seed-applied products. The region has the longest-established supplier base, with Bacillus thuringiensis, spinosyn and Bacillus subtilis products sold through retail and distributor networks.

United States

The United States accounted for 73.04% of North American revenue in 2025 and is projected to reach USD 2.19 billion in 2035. California, Florida and Pacific Northwest growers of fruit, nuts and vegetables are the core buyers, and the EPA's biopesticide division handles registration, with a dedicated approval track that is shorter than for conventional actives in principle although decisions often run late. The retail channel, organic-input listings and large insect and disease pressure in specialty crops give the United States the deepest product range in the region.

Canada

Canada was worth USD 403 million in 2025 and is projected to reach USD 809 million in 2035. Greenhouse vegetables, blueberries, apples and prairie field crops drive purchases, and the Pest Management Regulatory Agency's registrations decide timing, with products often arriving later than in the United States. Suppliers use Canadian label additions to extend U.S. products into horticulture, and short seasons and cool conditions give seed treatments and soil products a practical role.

Europe Biorationals Market Analysis

Europe accounted for 22.00% of 2025 revenue and is expected to reach USD 3.45 billion by 2035. The European Union's long-running withdrawal of chemical actives and the Farm to Fork target for lower chemical pesticide use push growers of vines, orchards and vegetables toward biological and low-risk products, but product authorization is national and slow. Organic farming land and strict retailer standards add pull. The region has the most active specialist supplier base, including baculovirus, pheromone and microbial developers.

Germany

Germany was worth USD 286 million in 2025 and is projected to reach USD 690 million in 2035. Wine, hops, potatoes, vegetables and orchard crops use biologicals, and the Federal Office of Consumer Protection and Food Safety authorizes products. Germany also serves as a regulatory reference for central European markets, because its zonal assessments set the pace for neighboring countries. Strong organic retail and a large biocontrol supplier base support demand, though conservative authorizations slow new entrants.

United Kingdom

The United Kingdom held a 12.03% share of European revenue in 2025 and is projected to reach USD 415 million in 2035. Berries, protected edibles and top fruit growers are the key buyers, and the Health and Safety Executive runs a separate national authorization system after Brexit. Supermarket residue standards are among the strictest in the world, which sustains demand for biological controls on strawberries and raspberries, and integrated pest management is already established practice in protected crops.

France

France was worth USD 257 million in 2025 and is projected to hold a 17.97% share of European revenue in 2035. Vineyards, orchards and vegetables are the core markets, and the national biocontrol list, maintained by the agriculture ministry, gives qualifying products priority in authorization and access to incentives. Downy mildew and powdery mildew pressure in grapes keeps demand for biofungicides and copper alternatives high, and farmers face public pressure to cut pesticide use near homes and schools.

Italy

Italy held a 15.03% share of European revenue in 2025 and a 15.04% share in 2035 projections, holding its place within a growing regional total. Vineyards, table grapes, tomatoes, citrus and orchards are the buyers, and the market has a strong pheromone mating-disruption tradition and emergency-authorization practice for new botanicals. Italian growers sell premium fruit and wine into export chains with residue standards, so uptake follows trade requirements.

Latin America Biorationals Market Analysis

Latin America held a 17.00% share of 2025 revenue and is forecast to grow at 10.71% a year. Brazil dominates the region, supported by large row-crop acreage, a federal bioinputs law and a record flow of registrations, and growers there have unusually strong know-how in multiplying microbes on farm. Mexico supplies export horticulture to U.S. buyers. Large suppliers have opened local plants and partnered with Brazilian biotechnology firms to reach soybean, corn, sugarcane and coffee growers.

Brazil

Brazil is projected to hold an 83.24% share of Latin American revenue in 2035 and was worth USD 920 million in 2025. Soybean, corn, sugarcane, coffee and citrus growers buy Trichoderma, Bacillus, baculovirus and entomopathogenic fungi products, and the ministry's registration process and on-farm biofactory culture shape competition. Brazil's pest pressure is year-round in the tropics, with multiple crop cycles, so growers run biologicals through the season rather than only as an add-on. Global suppliers have invested locally to hold their position.

Mexico

Mexico is projected to reach USD 304 million in 2035 and held a 9.95% share of Latin American revenue in 2025. Export tomatoes, berries, avocados and peppers are the core buyers, and U.S. residue tolerances and retail standards push growers toward biologicals and mineral inputs. Protected agriculture in the north and center uses Bacillus, Trichoderma and plant-extract products, and registration follows the federal agencies with additional scrutiny for new microbial strains.

MEA Biorationals Market Analysis

MEA is projected to hold a 7.47% share of 2035 revenue and to reach USD 1.25 billion in that year. It is the smallest region, with demand concentrated in export fruit and vegetables in South Africa, protected agriculture in the Gulf and a fragmented smallholder base in Africa, where registration capacity and distribution are the constraints. Growth comes from a low base, and suppliers rely on distributors and partnerships rather than direct sales.

South Africa

South Africa was worth USD 91 million in 2025 and is projected to hold a 20.02% share of MEA revenue in 2035. Citrus, table grapes, pome fruit and macadamia growers sell into European and Asian markets whose residue rules favor biologicals, and the national registration system covers pesticides under a dedicated act. Local formulators and international suppliers compete for these export growers, who are among the most technically sophisticated on the continent.

Saudi Arabia

Saudi Arabia held an 18.02% share of MEA revenue in 2025 and is projected to reach USD 227 million in 2035. Greenhouse vegetables, dates and large irrigated farms drive demand under national food-security programs, and pheromone traps for red palm weevil are a familiar input. Imports supply most products, so suppliers depend on local distributors and approval by the food and drug authority, and protected cultivation gives biological controls a practical role.

UAE

The UAE was worth USD 55 million in 2025 and is projected to reach USD 152 million in 2035. Cultivated area is limited, but greenhouse and vertical farms, high-value produce and strong import infrastructure create a niche for premium biological and low-residue products. Buyers are commercial operators with technical staff, and the market works as a regional showcase for suppliers that serve the Gulf from a Dubai base.

GMI Analyst View

Regional growth follows registration speed and crop structure more than farm income. Latin America and Asia Pacific offer the largest pools of row-crop and smallholder demand, and their policy direction favors biologicals, while Europe depends on how fast authorization improves and North America on whether U.S. review delays ease. National markets that sell into export chains, such as Mexico, South Africa and Italy, move earlier because retailers set the rules. Suppliers with local manufacturing and registration teams will outperform those that export from headquarters.

Biorationals Market Share & Competitive Landscape

The biorationals market is fragmented, and biorationals market share is spread between diversified crop protection groups whose biological lines sit inside much larger chemical and seed businesses and a long tail of specialists. Below the majors stand biocontrol companies, pheromone makers, fermentation houses and regional manufacturers in Brazil, China and India. Suppliers compete on strain performance, formulation stability, registration portfolios in key countries, access to seed and distributor channels and manufacturing scale. The field divides into integrated majors that acquire and partner for technology, specialists that own a particular organism or pheromone and regional producers that win on price and local registration.

BASF SE held a 6.92% share of 2025 revenue. Its BioSolutions portfolio covers biological fungicides and insecticides within integrated pest management programs, and the company closed its acquisition of AgBiTech on March 31, 2026, adding nucleopolyhedrovirus-based caterpillar control with manufacturing in the United States, Australia and Brazil [5]. The deal gives BASF a locally produced insect control line for Brazilian soybean, corn and cotton, where lepidopteran pests are a persistent problem.

Corteva Agriscience also held a 6.92% share. The company has announced Goltrevo, its first bioinsecticide, based on a Beauveria bassiana strain aimed at sap-feeding and chewing insects in corn, soybean, sugarcane and fruit, and it plans to hold biologicals within the crop protection company that results from its planned separation from the seed business. Corteva's biological position builds on spinosyn chemistry and on acquisitions that gave it microbial and nutrition platforms.

Syngenta AG held a 4.92% share. It has expanded biologicals through the acquisition of a Novartis collection of natural compounds and strains, the start-up of a biologicals plant in Orangeburg, South Carolina, and collaborations with Provivi on pheromones for Asia and with Ginkgo Bioworks. Its advantage is the seed and seed-care channel, which lets it place microbial products alongside treated seed in the Americas and Europe.

Bayer AG sells biological fungicides such as Serenade and Sonata under a global heritage in Bacillus products and has launched a Biológicos Bayer umbrella brand in Latin America. The company works with Brazilian biotechnology firm IdeeLab on a foliar fungicide for soybean and with Ginkgo Bioworks on nitrogen-fixing microbes, with its focus on tropical row crops where fungal disease is costly.

Sumitomo Chemical Co., Ltd. has consolidated its U.S. biorational subsidiaries, Valent BioSciences, McLaughlin Gormley King and Valent North America, into Sumitomo Biorational Company LLC, based in Libertyville, Illinois, as a global hub for research, manufacturing and sales. The Valent BioSciences heritage in Bacillus thuringiensis fermentation gives the group a base in microbial insect control and in forestry and public-health uses beyond agriculture.

Koppert B.V. is a Dutch specialist best known for Trianum, a Trichoderma harzianum biofungicide for soil-borne disease, and for a broad range of microbial and natural products for protected vegetable and fruit growers. It runs a strong Brazilian business and sells through its own sales and advisory staff, a model that combines product with agronomic support.

Gowan Company LLC, headquartered in Yuma, Arizona, has built a biological line through partnerships and acquisitions. It sells a botanical fungicide extracted from Swinglea glutinosa under the names EcoSwing in Canada and Perimeter in Brazil and Italy, took over U.S. sales of the Bio-Tam biofungicide from SePRO, and has partnered with Antofénol on a grapevine-derived fungicide for European vineyards.

Other named competitors fall into two groups. Specialist biocontrol and fermentation companies include Certis Biologicals, a microbial and biochemical pesticide supplier; Suterra LLC and Russell IPM Ltd, which focus on pheromone-based pest management; Andermatt Biocontrol AG, known for baculovirus products; Biobest Group, a supplier of biological control and pollination systems; and Novonesis, a biosolutions company with microbial strain and fermentation expertise.

Diversified crop protection producers with biological or nature-derived lines include UPL, FMC Corporation, Nufarm and Isagro SpA. These companies sell biologicals through established distribution networks and generic-chemical customer relationships, and they compete with the larger groups mainly in Latin America, Asia and Europe.

Recent Industry Developments

September 2026: Koppert launched Macan, a biological foliar fungicide based on Bacillus velezensis strain CECT 8237, for soybean, corn and sugarcane growers in Brazil after registering it at the end of 2025. The product is registered for 13 disease targets, including rusts, leaf spot and target spot, and the company reports it remains biologically active on the leaf surface after application [6].

June 2026: Bayer and Belgian developer Aphea.Bio signed a research partnership on June 9, 2026 to develop bioinsecticides from microbial metabolites against sap-sucking insects, starting with pome, stone, citrus and grape crops and with possible extension to vegetables, cotton and soybean. Financial terms were not disclosed [7].

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.


Authors:  Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQs):

The biorationals market size was estimated at USD 6.5 billion in 2025 and is expected to reach USD 7.15 billion in 2026.
The market is projected to reach USD 16.85 billion by 2035, growing at a CAGR of 10.00% from 2026 to 2035.
Asia Pacific currently holds the largest share of the biorationals market in 2025.
Asia Pacific is projected to be the fastest-growing region during the forecast period.
Some of the major players in biorationals market include BASF SE, Corteva Agriscience, Syngenta AG, Bayer AG, Sumitomo Chemical Co., Ltd..

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 20+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Industry journals, trade publications, and specialized media.

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 20+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Kiran Pulidindi, Kunal Ahuja
We use cookies to enhance user experience. (Privacy Policy)